Chunyan Chen
Department Of Head And Neck Surgery
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Adjuvant radiotherapy for patients with clinical T3-4 oral and oropharyngeal cancer who achieved major pathologic response after neoadjuvant immunochemotherapy and surgery: a propensity score-matched retrospective study.
Journal: Frontiers in immunology
Published: August 07, 2025
Deep learning enhanced MRI radiomics in predicting pathological response of head and neck squamous carcinoma to neoadjuvant chemoimmunotherapy: a retrospective analysis.
Journal: International journal of surgery (London, England)
Published: June 26, 2025
Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2025
CNG (Collaborative Nasopharyngeal Carcinoma Group) stage: Improved prognostic stratification of nasopharyngeal carcinoma and association with Epstein-Barr virus DNA in the intensity-modulated radiation therapy era.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 24, 2024
PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes.
Journal: Frontiers in immunology
Published: December 10, 2023
Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma.
Journal: Cancer medicine
Published: January 24, 2021
Contralateral Lower Neck Sparing Radiotherapy in Stage N1 Nasopharyngeal Carcinoma: Long-Term Survival Outcomes and Late Toxicities.
Journal: Frontiers in oncology
Published: November 13, 2020
Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen.
Journal: Frontiers in oncology
Published: March 08, 2020
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.
Journal: Scientific reports
Published: May 04, 2016
Concurrent chemotherapy with different dose regimens of cisplatin for nasopharyngeal carcinoma using intensity-modulated radiation therapy: a phase II prospective randomized controlled trial
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: January 09, 2015
Last Updated: 09/26/2026